Paclitaxel Injection Market Driven by Increasing Scope of Use as Anti-cancer Drug

Transparency Market Research has compiled a vast amount of data on the global pharmaceutical drugs and devices industry. One of the latest data compilations will be placed under the title “Paclitaxel Injection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019.”

Get Free Sample Research Report:
http://goo.gl/GPRU7d

Paclitaxel is a drug that finds major use in the treatment of cancer of the ovaries, breasts, pancreas, lungs, and others. It is one of the members of the docetaxel drug family and works by creating interference during the division of cancer cells. It is a cytoskeletal drug that targets a cell’s globular proteins known as tubulins. This drug is also included in the List of Essential Medicines by the World Health Organization, making is a basic necessity for any healthcare system to procure it.

Paclitaxel is a viscous chemical that is gathered from the Pacific yew tree’s bark. It is an antineoplastic that is useful in the treatment of advanced stages of cancer. The various types of cancer for which Paclitaxel is prescribed include fallopian tube cancer, testicular cancer, stomach cancer, Kaposi’s sarcoma, non-small cell lung cancer, throat cancer, endometrial cancer, cervical cancer, esophageal cancer, and bladder cancer. The yew tree is, however, a very slow growing one and the large scale felling of yew trees could pose a major problem to both the environment as well as the future production of Paclitaxel.

One of the primary drivers of the global Paclitaxel injections market is the inherent advantages of using Paclitaxel for cancer treatment. This includes the high efficacy of the drug, the speed of treatment, and easy availability of the drug.

On the other hand, the possibility of triggering allergic reactions, diarrhea, fever, blood clots, and unnatural weight loss is a major challenge to the global Paclitaxel injection market, which can prove to be detrimental to the overall growth of the market. Another restraint to the global Paclitaxel injection market is the regulatory pressure mounted against the uncontrolled generation of the drug.

North America is the largest region in the global Paclitaxel injection market owing to a high number of patients seeking treatment of various cancers. On the other hand, the regions of Asia Pacific and Europe are showing major growth potential in the global Paclitaxel injection market due to a growing number of cancer diagnoses.

The key players in the global Paclitaxel injection market include Novasep, Sagent Pharmaceuticals Inc., Strides Arcolab Ltd., Onco Therapies Ltd., Fresenius Kabi Oncology Ltd., Bristol-Myers Squibb, Abbott Laboratories, and AbraxisBioScience Inc.l-injection-market.html

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

90 State Street, Suite 700 Albany, NY 12207

This release was published on openPR.